| Year |
Citation |
Score |
| 2017 |
Stein AM, Grupp SA, Levine JE, Laetsch TW, Pulsipher MA, Boyer MW, August KJ, Levine BL, June CH, Tomassian L, Shah S, Leung M, Huang P, Jolivet S, Awasthi R, et al. CTL019 Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor (CAR) T Cells to Characterize the Impact of Tocilizumab on Expansion and to Identify Correlates of Cytokine Release Syndrome Severity Blood. 130: 2561-2561. DOI: 10.1182/Blood.V130.Suppl_1.2561.2561 |
0.339 |
|
| 2016 |
Goel V, Hurh E, Stein A, Nedelman J, Zhou J, Chiparus O, Huang PH, Gogov S, Sellami D. Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. PMID 26898300 DOI: 10.1007/S00280-016-2982-1 |
0.333 |
|
| 2013 |
Stein A, Bellmunt J, Escudier B, Kim D, Stergiopoulos SG, Mietlowski W, Motzer RJ. Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 trial European Urology. 64: 994-1002. PMID 23219086 DOI: 10.1016/J.Eururo.2012.11.032 |
0.35 |
|
| 2013 |
Mietlowski WL, Stein AM, Bao W, Waltzman RJ, Wood PA. Prognostic value of waterfall plots with the addition of nontarget lesion data. Journal of Clinical Oncology. 31: 11082-11082. DOI: 10.1200/Jco.2013.31.15_Suppl.11082 |
0.324 |
|
| 2012 |
Stein A, Wang W, Carter AA, Chiparus O, Hollaender N, Kim H, Motzer RJ, Sarr C. Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial. Bmc Cancer. 12: 311. PMID 22824201 DOI: 10.1186/1471-2407-12-311 |
0.363 |
|
| 2012 |
Mietlowski WL, Bao W, Wood PA, Williams DE, El-Hashimy M, Sarr C, Stein AM, Shi M, Weber D, Habr D, Porro MG. Clinical importance of including new and nontarget lesion assessment of disease progression (PD) to predict overall survival (OS): Implications for randomized phase II study design. Journal of Clinical Oncology. 30: 2543-2543. DOI: 10.1200/Jco.2012.30.15_Suppl.2543 |
0.34 |
|
| 2011 |
Stein AM, Carter A, Hollaender N, Motzer RJ, Sarr C. Quantifying the effect of everolimus on both tumor growth and new metastases in metastatic renal cell carcinoma (RCC): A dynamic tumor model of the RECORD-1 phase III trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4602. PMID 28024008 DOI: 10.1200/Jco.2011.29.15_Suppl.4602 |
0.374 |
|
| 2011 |
Reddy PL, Choppa P, Moradian MM, Potter NT, Quigley MM, Watt CD, Höfling H, Manning B, Mignault A, Mullaney B, Ossa D, Stein A, Wang S, Yang F, Wetzler M. Evaluation of MMR Concordance Based on Either International Scale (IS) or National Comprehensive Cancer Network (NCCN) Criteria Using Reconstructed “Virtual” CML Patient Profiles From the REVEAL BCR-ABL Methods Comparison Study, Blood. 118: 3542-3542. DOI: 10.1182/Blood.V118.21.3542.3542 |
0.301 |
|
| 2011 |
Stein A, Wang W, Carter A, Chiparus O, Hollaender N, Motzer R, Sarr C. 728 Dynamic Tumor Modelling Of The Record-1 Phase Ii Trial Of Everolimus Quantifies Relationship Between Dose And Tumor Growth In Metastatic Renal Cell Carcinoma European Urology Supplements. 10: 232. DOI: 10.1016/S1569-9056(11)60716-1 |
0.372 |
|
| 2011 |
Stein AM, Vader DA, Weitz DA, Sander LM. The micromechanics of three-dimensional collagen-I gels Complexity. 16: 22-28. DOI: 10.1002/Cplx.20332 |
0.501 |
|
| 2009 |
Bottino D, Chia Y, Stein A, Georgieva A, Yu J, Kahn J, Helmlinger G, Kalebic T. Inference of imatinib (IM) effects on leukemic stem cell (SC) compartment via mathematical modeling of IRIS treatment response data. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 7056. PMID 27961444 DOI: 10.1200/Jco.2009.27.15_Suppl.7056 |
0.311 |
|
| 2009 |
Stein A, Kalebic T, Bottino D. Bcr-Abl Kinetics Suggest Self-Renewing Leukemic Cells Are Reduced During Imatinib Treatment. Blood. 114: 506-506. DOI: 10.1182/Blood.V114.22.506.506 |
0.331 |
|
| 2008 |
Stein AM, Vader DA, Jawerth LM, Weitz DA, Sander LM. An algorithm for extracting the network geometry of three-dimensional collagen gels. Journal of Microscopy. 232: 463-75. PMID 19094023 DOI: 10.1111/J.1365-2818.2008.02141.X |
0.488 |
|
| 2008 |
Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA, Lawler S. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro-Oncology. 10: 690-9. PMID 18715951 DOI: 10.1215/15228517-2008-041 |
0.534 |
|
| 2008 |
Vader D, Muenster S, Jawerth L, Stein A, Fabry B, Weitz D. LARGE AMPLITUDE OSCILLATORY SHEAR IN COLLAGEN RHEOLOGY SHOWS EARLY STRAIN STIFFENING Journal of Biomechanics. 41: S318. DOI: 10.1016/S0021-9290(08)70317-8 |
0.304 |
|
| 2007 |
Stein AM, Nowicki MO, Demuth T, Berens ME, Lawler SE, Chiocca EA, Sander LM. Estimating the cell density and invasive radius of three-dimensional glioblastoma tumor spheroids grown in vitro. Applied Optics. 46: 5110-8. PMID 17676121 DOI: 10.1364/Ao.46.005110 |
0.552 |
|
| 2007 |
Stein AM, Demuth T, Mobley D, Berens M, Sander LM. A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. Biophysical Journal. 92: 356-65. PMID 17040992 DOI: 10.1529/Biophysj.106.093468 |
0.575 |
|
| 2005 |
Khain E, Sander LM, Stein AM. A model for glioma growth Complexity. 11: 53-57. DOI: 10.1002/Cplx.V11:2 |
0.545 |
|
| Show low-probability matches. |